Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Alzheimer & Dementia Related Cognitive Disorders Topic Center

Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
News
Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
04/29/2024
Jolynn Tumolo
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease...
04/29/2024
Neurology
From Neurology
Illustration of the brain
News
Antipsychotics for Dementia Associated With More Adverse Outcomes Than Previously Thought
04/22/2024
Jolynn Tumolo
Antipsychotic use in patients with dementia is associated with an increased risk for a handful of serious adverse outcomes, including pneumonia, acute kidney injury, venous thromboembolism, and stroke.
Antipsychotic use in patients with dementia is associated with an increased risk for a handful of serious adverse outcomes, including pneumonia, acute kidney injury, venous thromboembolism, and stroke.
Antipsychotic use in patients...
04/22/2024
Psych Congress Network
Doctors examine brain scans
News
Rate of Frontotemporal Dementia in Patients With ALS Higher Than Previous Estimates
03/04/2024
Jolynn Tumolo
More than a third of patients with amyotrophic lateral sclerosis (ALS) had neuropathological signs of frontotemporal dementia, according to study results published in Brain.
More than a third of patients with amyotrophic lateral sclerosis (ALS) had neuropathological signs of frontotemporal dementia, according to study results published in Brain.
More than a third of patients...
03/04/2024
Neurology
From Neurology
Brain scan
News
Study Reveals Structural Brain Subgroups in Aging, Key for Early Disease Detection
03/01/2024
Meagan Thistle
Recent study reveals significant insights into the structural brain changes associated with aging in individuals without diagnosed cognitive impairment.
Recent study reveals significant insights into the structural brain changes associated with aging in individuals without diagnosed cognitive impairment.
Recent study reveals significant...
03/01/2024
Psych Congress Network
An elderly patient with Alzheimer disease looks up at their caregiver
AVP-786 Falls Short in Phase 3 Trial for Agitation in Alzheimer Patients
02/16/2024
Meagan Thistle
Otsuka Pharmaceutical Co., Ltd. unveiled the topline results of the phase 3 clinical trial of AVP-786 in treating agitation associated with dementia due to Alzheimer disease.
Otsuka Pharmaceutical Co., Ltd. unveiled the topline results of the phase 3 clinical trial of AVP-786 in treating agitation associated with dementia due to Alzheimer disease.
Otsuka Pharmaceutical Co., Ltd....
02/16/2024
Psych Congress Network
A doctor examines MRI scans of a brain.
News
Low-Dose IL-2 Shows Potential for Alzheimer Disease, Phase 2a Trial Underway
02/07/2024
Jolynn Tumolo
After promising findings in a small, open-label, phase 1 pilot study of low-dose interleukine-2 (IL-2) immunotherapy in patients with Alzheimer disease (AD), researchers are proceeding with a double-blinded, randomized, placebo-controlled,...
After promising findings in a small, open-label, phase 1 pilot study of low-dose interleukine-2 (IL-2) immunotherapy in patients with Alzheimer disease (AD), researchers are proceeding with a double-blinded, randomized, placebo-controlled,...
After promising findings in a...
02/07/2024
Neurology
From Neurology
Hearing Loss Prevention Could Delay, Prevent Dementia Onset
News
Hearing Loss Prevention Could Delay, Prevent Dementia Onset
01/29/2024
Evi Arthur
Hearing aids could delay or prevent dementia onset, according to a population-based cohort study recently published in the journal JAMA Otolaryngology Head & Neck Surgery.
Hearing aids could delay or prevent dementia onset, according to a population-based cohort study recently published in the journal JAMA Otolaryngology Head & Neck Surgery.
Hearing aids could delay or...
01/29/2024
Psych Congress Network
Excessive TV Use Could Raise Risk of Dementia, PD, and Depression
News
Excessive TV Use Could Raise Risk of Dementia, PD, and Depression
01/15/2024
Evi Arthur
Excessive TV watching was associated with an increased risk of dementia, Parkinson disease (PD), and depression, according to recent study results.
Excessive TV watching was associated with an increased risk of dementia, Parkinson disease (PD), and depression, according to recent study results.
Excessive TV watching was...
01/15/2024
Neurology
From Neurology
Multiple Modifiable Risk Factors Connected to Young-Onset Dementia
News
Multiple Modifiable Risk Factors Connected to Young-Onset Dementia
01/10/2024
Evi Arthur
Factors such as social isolation, vitamin D deficiency, and alcohol use disorder, among others, were significantly associated with a higher risk of young-onset dementia (YOD) in a recent prospective cohort study published in JAMA Neurology. 
Factors such as social isolation, vitamin D deficiency, and alcohol use disorder, among others, were significantly associated with a higher risk of young-onset dementia (YOD) in a recent prospective cohort study published in JAMA Neurology. 
Factors such as social...
01/10/2024
Neurology
From Neurology
alzheimer sleep
News
Decline in Slow-Wave Sleep Linked to Increased Dementia Risk
11/30/2023
Meagan Thistle
Researchers have identified a potential link between decreased slow-wave sleep (SWS)—a crucial sleep cycle phase—and Alzheimer risk.
Researchers have identified a potential link between decreased slow-wave sleep (SWS)—a crucial sleep cycle phase—and Alzheimer risk.
Researchers have identified a...
11/30/2023
Psych Congress Network
BIIB080 Reduces Tau Biomarkers in Patients With Mild Alzheimer Disease
News
BIIB080 Reduces Tau Biomarkers in Patients With Mild Alzheimer Disease
11/28/2023
Jolynn Tumolo
BIIB080 reduced biomarkers associated with tau pathophysiology in patients with mild Alzheimer disease, according to results from a phase 1b trial published in JAMA Neurology.
BIIB080 reduced biomarkers associated with tau pathophysiology in patients with mild Alzheimer disease, according to results from a phase 1b trial published in JAMA Neurology.
BIIB080 reduced biomarkers...
11/28/2023
Psych Congress Network

Quizzes

Why do hurricanes increase mortality risk in ADRD populations?
Quiz
Why do hurricanes increase mortality risk in ADRD populations?
04/04/2023
Do you remember this study?
Do you remember this study?
Do you remember this study?
04/04/2023
Psych Congress Network
Four pencils with their erasers spelling out "quiz."
Quiz
What strategies can individuals use to reduce their risk of Alzheimer disease?
09/28/2022
Take the quiz to test your clinical knowledge!
Take the quiz to test your clinical knowledge!
Take the quiz to test your...
09/28/2022
Psych Congress Network
Pencils spell out quiz on their erasers
Quiz
Which tech challenges can telehealth providers expect to encounter most often?
05/14/2024
Hone your telepsychiatry skills with this quiz!
Hone your telepsychiatry skills with this quiz!
Hone your telepsychiatry skills...
05/14/2024
Psych Congress Network
Does in utero stimulant use increase risk of childhood neurodevelopmental disorders?
Quiz
Does in utero stimulant exposure increase risk of childhood neurodevelopmental disorders?
05/12/2024
Test your knowledge!
Test your knowledge!
Test your knowledge!
05/12/2024
Psych Congress Network
Why can bipolar disorder often be misdiagnosed as MDD?
Expert Insights Quiz
Why is bipolar disorder often misdiagnosed as MDD?
05/10/2024
Do you remember this Q&A with Dr Roger McIntyre?
Do you remember this Q&A with Dr Roger McIntyre?
Do you remember this Q&A with Dr...
05/10/2024
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy.
Quiz
Pediatric ADHD and Schizophrenia Risk
05/01/2024
Test your psychiatry knowledge with this quiz!
Test your psychiatry knowledge with this quiz!
Test your psychiatry knowledge...
05/01/2024
Psych Congress Network
FDA
Quiz
What were the FDA's preliminary findings after investigating GLP-1 RAs?
04/25/2024
Do you remember this FDA update?
Do you remember this FDA update?
Do you remember this FDA update?
04/25/2024
Psych Congress Network
Quiz
For TD, the APA recommends performing an assessment with a structured instrument how often?
04/18/2024
When treating tardive dyskinesia (TD), the American Psychiatric Association (APA) recommends performing an assessment with a structured instrument (e.g., AIMS, DISCUS) how often?
When treating tardive dyskinesia (TD), the American Psychiatric Association (APA) recommends performing an assessment with a structured instrument (e.g., AIMS, DISCUS) how often?
When treating tardive dyskinesia...
04/18/2024
Psych Congress Network
PCN quiz
Quiz
For TD, the APA recommends performing an assessment with a structured instrument how often?
04/18/2024
When treating tardive dyskinesia (TD), the American Psychiatric Association (APA) recommends performing an assessment with a structured instrument (e.g., AIMS, DISCUS) how often?
When treating tardive dyskinesia (TD), the American Psychiatric Association (APA) recommends performing an assessment with a structured instrument (e.g., AIMS, DISCUS) how often?
When treating tardive dyskinesia...
04/18/2024
Psych Congress Network
Women with ADHD are diagnosed how many years after men?
Quiz
Women with ADHD are diagnosed how many years after men?
04/17/2024
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
04/17/2024
Psych Congress Network
In an illustrated cartoon style, a man sits on the ground with his head in his hands
Quiz
Global Schizophrenia Care Rates
04/15/2024
Put your knowledge to the test with this quick quiz!
Put your knowledge to the test with this quick quiz!
Put your knowledge to the test...
04/15/2024
Psych Congress Network
Do men or women have an earlier age at onset of OCD?
Quiz
Do men or women have an earlier age at onset of OCD?
03/22/2024
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your diagnostic knowledge!
Do a quick refresh on your...
03/22/2024
Psych Congress Network

Insights

Leslie Citrome, MD, MPH.
Videos
Addressing Agitation in Dementia
11/09/2023

Featuring Leslie Citrome, MD, MPH

Featuring Leslie Citrome, MD, MPH ...
With 7 million individuals living with Alzheimer disease and dementia in the United States, effective home-based strategies are crucial to prevent institutionalization.
With 7 million individuals living with Alzheimer disease and dementia in the United States, effective home-based strategies are crucial to prevent institutionalization.
With 7 million individuals...
11/09/2023
Psychiatry & Behavioral Health
Dr Paul Schulz
Videos
Lecanemab Considerations and Efficacy
10/16/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/16/2023
Psych Congress Network
Dr Paul Schulz
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
09/22/2023

With Paul Schulz, MD

With Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
09/22/2023
Psych Congress Network
Dr Paul Schulz
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
09/11/2023

With Paul Schulz, MD 

With Paul Schulz, MD 
Dr Paul Shulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Shulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Shulz discusses the...
09/11/2023
Psych Congress Network
Marc Agronin, MD.
Videos
Telepsychiatry Practice for Geriatric Patients
08/11/2023

Featuring Marc Agronin, MD

Featuring Marc Agronin, MD
In this exclusive video, Psych Congress Network Geriatric Psychiatry Section Editor Marc Agronin, MD, CMO, describes his experience treating geriatric patients via telehealth.
In this exclusive video, Psych Congress Network Geriatric Psychiatry Section Editor Marc Agronin, MD, CMO, describes his experience treating geriatric patients via telehealth.
In this exclusive video, Psych...
08/11/2023
Psych Congress Network
Marc Agronin, MD.
Videos
What the Data Tells Us About Telepsychiatry Efficacy and Popularity
07/20/2023

Featuring Marc Agronin, MD

Featuring Marc Agronin, MD
Psych Congress Network Geriatric Psychiatry Section Editor Marc Agronin, MD, discusses the meteoric rise of telehealth in mental health care practice.
Psych Congress Network Geriatric Psychiatry Section Editor Marc Agronin, MD, discusses the meteoric rise of telehealth in mental health care practice.
Psych Congress Network Geriatric...
07/20/2023
Psych Congress Network
Marc Agronin, MD.
Blog
Alzheimer Disease Prevention
08/30/2022
Marc Agronin, MD
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section Editor Mark Agronin, MD, provides expert clinical insights on reducing the risk for Alzheimer disease and delaying its onset and progression.
Psych Congress Network Section...
08/30/2022
Psych Congress Network
Douglas_Scharre_alzheimers_aducanumab
Videos
Putting Research Into Practice With Aducanumab for Alzheimer Disease
08/27/2021
In this video, Douglas Scharre, MD discusses his presentation “Translating Research Into Practice Everything You Need To Know About Aducanumab But Were Afraid To Ask,” which was given virtually at Neurology Week.
In this video, Douglas Scharre, MD discusses his presentation “Translating Research Into Practice Everything You Need To Know About Aducanumab But Were Afraid To Ask,” which was given virtually at Neurology Week.
In this video, Douglas Scharre,...
08/27/2021
Psych Congress Network
Improving Cognition in Patients With Alzheimer’s Disease
Videos
Improving Cognition in Patients With Alzheimer’s Disease
11/11/2020
In this video, geriatric psychiatrist Marc E. Agronin, MD, discusses medications that may improve cognition in patients with Alzheimer's disease.
In this video, geriatric psychiatrist Marc E. Agronin, MD, discusses medications that may improve cognition in patients with Alzheimer's disease.
In this video, geriatric...
11/11/2020
Psych Congress Network
Flavonol Consumption Linked With Lower Risk of Alzheimer’s Dementia
Podcasts
Flavonol Consumption Linked With Lower Risk of Alzheimer’s Dementia
02/06/2020
Consuming more food and drink with the antioxidant flavonol is associated with a smaller chance of developing Alzheimer’s dementia years later, researchers reported in Neurology.
Consuming more food and drink with the antioxidant flavonol is associated with a smaller chance of developing Alzheimer’s dementia years later, researchers reported in Neurology.
Consuming more food and drink...
02/06/2020
Psych Congress Network
Kevin Williams, MS, MPAS, PA-C,
Videos
Unpacking the Patient Experience of Living With Tardive Dyskinesia
05/14/2024

Featuring Kevin Williams, MS, MPAS, PA-C

Featuring Kevin Williams, MS, MPAS, P...
Kevin Williams, MS, MPAS, PA-C, discusses the often-overlooked social and professional dimensions of life with tardive dyskinesia (TD).
Kevin Williams, MS, MPAS, PA-C, discusses the often-overlooked social and professional dimensions of life with tardive dyskinesia (TD).
Kevin Williams, MS, MPAS, PA-C, ...
05/14/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
Differentiating Between BPD and Bipolar Disorder in Clinical Practice
05/14/2024

With Rakesh Jain, MD, and Craig Chepke, MD

With Rakesh Jain, MD, and Craig Chepk...
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig...
05/14/2024
Psych Congress Network
Greg Mattingly, MD
Videos
The Future Role of Orexin Agonists for the Treatment of Narcolepsy, EDS, and Beyond
05/13/2024

Featuring Greg Mattingly, MD

Featuring Greg Mattingly, MD
Greg Mattingly, MD, explains how sleep can become disrupted and the novel solutions that the orexin receptor may make possible.
Greg Mattingly, MD, explains how sleep can become disrupted and the novel solutions that the orexin receptor may make possible.
Greg Mattingly, MD, explains how...
05/13/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
Managing Adverse Effects and Medication Changes in Bipolar Disorder
05/07/2024
In this podcast, Drs Craig Chepke and Rakesh Jain discuss switching medications and avoiding adverse effects like weight gain in bipolar disorder treatment.
In this podcast, Drs Craig Chepke and Rakesh Jain discuss switching medications and avoiding adverse effects like weight gain in bipolar disorder treatment.
In this podcast, Drs Craig...
05/07/2024
Psych Congress Network
Edward Kaftarian, MD.
Videos
Addressing Technological Challenges in Telehealth
05/03/2024

Featuring Edward Kaftarian, MD

Featuring Edward Kaftarian, MD ...
In this video, Edward Kaftarian, MD, offers some insight into common technical challenges that telehealth providers may encounter and how to proactively address them.
In this video, Edward Kaftarian, MD, offers some insight into common technical challenges that telehealth providers may encounter and how to proactively address them.
In this video, Edward Kaftarian,...
05/03/2024
Psych Congress Network
Desiree Matthews, PHMNP-BC
Videos
Medication Limitations and Adverse Effects in Bipolar Disorder Treatment
04/29/2024

Featuring Desiree Matthews, PMHNP-BC

Featuring Desiree Matthews, PMHNP-BC ...
Join Desiree Matthews, PHMNP-BC, as she explores the limitations of traditional antipsychotic agents and off-label therapies in bipolar disorder treatment.
Join Desiree Matthews, PHMNP-BC, as she explores the limitations of traditional antipsychotic agents and off-label therapies in bipolar disorder treatment.
Join Desiree Matthews, PHMNP-BC,...
04/29/2024
Psych Congress Network
Desiree Matthews, PHMNP-BC
Videos
Common Challenges for Clinicians Prescribing Antipsychotics
04/22/2024

Featuring Desiree Matthews, PHMNP-BC

Featuring Desiree Matthews, PHMNP-BC ...
Join Nurse Matthews for an in-depth exploration of the primary challenges faced by clinicians treating patients with bipolar disorder.
Join Nurse Matthews for an in-depth exploration of the primary challenges faced by clinicians treating patients with bipolar disorder.
Join Nurse Matthews for an...
04/22/2024
Psych Congress Network
Penn and Jain
Videos
Healing Health Care Burnout and Lessons Learned From the COVID-19 Pandemic
04/16/2024

Featuring Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP

Featuring Saundra Jain, MA, PsyD, LPC...
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP, unpack the profound and lasting impacts of burnout among health care professionals in the wake of the COVID-19 pandemic.
Saundra Jain, MA, PsyD, LPC, and Andrew Penn, MS, PMHNP, unpack the profound and lasting impacts of burnout among health care professionals in the wake of the COVID-19 pandemic.
Saundra Jain, MA, PsyD, LPC, and...
04/16/2024
Psych Congress Network
Desiree Matthews, PMHNP-BC.
Videos
Tardive Dyskinesia: Impacts, Assessment, and Treatment Options
04/15/2024

Featuring Desiree Matthews, PMHNP-BC

Featuring Desiree Matthews, PMHNP-BC ...
Gain fresh insights into the multifaceted impacts of tardive dyskinesia (TD) with Desiree Matthews, PMHNP-BC, as she explores the physical, social, and emotional consequences faced by patients living with TD.
Gain fresh insights into the multifaceted impacts of tardive dyskinesia (TD) with Desiree Matthews, PMHNP-BC, as she explores the physical, social, and emotional consequences faced by patients living with TD.
Gain fresh insights into the...
04/15/2024
Psych Congress Network
Desiree Matthews, PMHNP-BC.
Videos
Tardive Dyskinesia: Impacts, Assessment, and Treatment Options
04/15/2024

Featuring Desiree Matthews, PMHNP-BC

Featuring Desiree Matthews, PMHNP-BC ...
Gain fresh insights into the multifaceted impacts of tardive dyskinesia (TD) with Desiree Matthews, PMHNP-BC, as she explores the physical, social, and emotional consequences faced by patients living with TD.
Gain fresh insights into the multifaceted impacts of tardive dyskinesia (TD) with Desiree Matthews, PMHNP-BC, as she explores the physical, social, and emotional consequences faced by patients living with TD.
Gain fresh insights into the...
04/15/2024
Psych Congress Network

Practice Tools

Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
News
Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
04/29/2024
Jolynn Tumolo
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease...
04/29/2024
Neurology
Illustration of the brain
News
Antipsychotics for Dementia Associated With More Adverse Outcomes Than Previously Thought
04/22/2024
Jolynn Tumolo
Antipsychotic use in patients with dementia is associated with an increased risk for a handful of serious adverse outcomes, including pneumonia, acute kidney injury, venous thromboembolism, and stroke.
Antipsychotic use in patients with dementia is associated with an increased risk for a handful of serious adverse outcomes, including pneumonia, acute kidney injury, venous thromboembolism, and stroke.
Antipsychotic use in patients...
04/22/2024
Psych Congress Network
Doctors examine brain scans
News
Rate of Frontotemporal Dementia in Patients With ALS Higher Than Previous Estimates
03/04/2024
Jolynn Tumolo
More than a third of patients with amyotrophic lateral sclerosis (ALS) had neuropathological signs of frontotemporal dementia, according to study results published in Brain.
More than a third of patients with amyotrophic lateral sclerosis (ALS) had neuropathological signs of frontotemporal dementia, according to study results published in Brain.
More than a third of patients...
03/04/2024
Neurology
Brain scan
News
Study Reveals Structural Brain Subgroups in Aging, Key for Early Disease Detection
03/01/2024
Meagan Thistle
Recent study reveals significant insights into the structural brain changes associated with aging in individuals without diagnosed cognitive impairment.
Recent study reveals significant insights into the structural brain changes associated with aging in individuals without diagnosed cognitive impairment.
Recent study reveals significant...
03/01/2024
Psych Congress Network
An elderly patient with Alzheimer disease looks up at their caregiver
AVP-786 Falls Short in Phase 3 Trial for Agitation in Alzheimer Patients
02/16/2024
Meagan Thistle
Otsuka Pharmaceutical Co., Ltd. unveiled the topline results of the phase 3 clinical trial of AVP-786 in treating agitation associated with dementia due to Alzheimer disease.
Otsuka Pharmaceutical Co., Ltd. unveiled the topline results of the phase 3 clinical trial of AVP-786 in treating agitation associated with dementia due to Alzheimer disease.
Otsuka Pharmaceutical Co., Ltd....
02/16/2024
Psych Congress Network
A doctor examines MRI scans of a brain.
News
Low-Dose IL-2 Shows Potential for Alzheimer Disease, Phase 2a Trial Underway
02/07/2024
Jolynn Tumolo
After promising findings in a small, open-label, phase 1 pilot study of low-dose interleukine-2 (IL-2) immunotherapy in patients with Alzheimer disease (AD), researchers are proceeding with a double-blinded, randomized, placebo-controlled,...
After promising findings in a small, open-label, phase 1 pilot study of low-dose interleukine-2 (IL-2) immunotherapy in patients with Alzheimer disease (AD), researchers are proceeding with a double-blinded, randomized, placebo-controlled,...
After promising findings in a...
02/07/2024
Neurology
Hearing Loss Prevention Could Delay, Prevent Dementia Onset
News
Hearing Loss Prevention Could Delay, Prevent Dementia Onset
01/29/2024
Evi Arthur
Hearing aids could delay or prevent dementia onset, according to a population-based cohort study recently published in the journal JAMA Otolaryngology Head & Neck Surgery.
Hearing aids could delay or prevent dementia onset, according to a population-based cohort study recently published in the journal JAMA Otolaryngology Head & Neck Surgery.
Hearing aids could delay or...
01/29/2024
Psych Congress Network
Excessive TV Use Could Raise Risk of Dementia, PD, and Depression
News
Excessive TV Use Could Raise Risk of Dementia, PD, and Depression
01/15/2024
Evi Arthur
Excessive TV watching was associated with an increased risk of dementia, Parkinson disease (PD), and depression, according to recent study results.
Excessive TV watching was associated with an increased risk of dementia, Parkinson disease (PD), and depression, according to recent study results.
Excessive TV watching was...
01/15/2024
Neurology
Multiple Modifiable Risk Factors Connected to Young-Onset Dementia
News
Multiple Modifiable Risk Factors Connected to Young-Onset Dementia
01/10/2024
Evi Arthur
Factors such as social isolation, vitamin D deficiency, and alcohol use disorder, among others, were significantly associated with a higher risk of young-onset dementia (YOD) in a recent prospective cohort study published in JAMA Neurology. 
Factors such as social isolation, vitamin D deficiency, and alcohol use disorder, among others, were significantly associated with a higher risk of young-onset dementia (YOD) in a recent prospective cohort study published in JAMA Neurology. 
Factors such as social...
01/10/2024
Neurology
alzheimer sleep
News
Decline in Slow-Wave Sleep Linked to Increased Dementia Risk
11/30/2023
Meagan Thistle
Researchers have identified a potential link between decreased slow-wave sleep (SWS)—a crucial sleep cycle phase—and Alzheimer risk.
Researchers have identified a potential link between decreased slow-wave sleep (SWS)—a crucial sleep cycle phase—and Alzheimer risk.
Researchers have identified a...
11/30/2023
Psych Congress Network
News
One Year After ‘X Waiver’ Axing, Few New Patients Prescribed Meds for OUD
05/15/2024
Brionna Mendoza
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of...
05/15/2024
Psych Congress Network
Kevin Williams, MS, MPAS, PA-C,
Unpacking the Patient Experience of Living With Tardive Dyskinesia
05/14/2024

Featuring Kevin Williams, MS, MPAS, PA-C

Featuring Kevin Williams, MS, MPAS, P...
Kevin Williams, MS, MPAS, PA-C, discusses the often-overlooked social and professional dimensions of life with tardive dyskinesia (TD).
Kevin Williams, MS, MPAS, PA-C, discusses the often-overlooked social and professional dimensions of life with tardive dyskinesia (TD).
Kevin Williams, MS, MPAS, PA-C, ...
05/14/2024
Psych Congress Network
Kevin Williams, MS, MPAS, PA-C,
Videos
Unpacking the Patient Experience of Living With Tardive Dyskinesia
05/14/2024

Featuring Kevin Williams, MS, MPAS, PA-C

Featuring Kevin Williams, MS, MPAS, P...
Kevin Williams, MS, MPAS, PA-C, discusses the often-overlooked social and professional dimensions of life with tardive dyskinesia (TD).
Kevin Williams, MS, MPAS, PA-C, discusses the often-overlooked social and professional dimensions of life with tardive dyskinesia (TD).
Kevin Williams, MS, MPAS, PA-C, ...
05/14/2024
Psych Congress Network
ketamine brain image
News
Study Findings Support Esketamine and Psilocybin as Effective TRD Treatments
05/14/2024
Meagan Thistle
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and...
05/14/2024
Psych Congress Network
Differentiating Between BPD and Bipolar Disorder in Clinical Practice Transcript
05/14/2024
Saundra Jain, PsyD: Welcome back, everyone. Hey, Dr Chepke, Dr Jain. It's great to be here with both of you this afternoon. Thanks for joining us. We have a ton of questions. So I say, let's jump in. Craig, I'm gonna start with you if you...
Saundra Jain, PsyD: Welcome back, everyone. Hey, Dr Chepke, Dr Jain. It's great to be here with both of you this afternoon. Thanks for joining us. We have a ton of questions. So I say, let's jump in. Craig, I'm gonna start with you if you...
Saundra Jain, PsyD: Welcome...
05/14/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
Differentiating Between BPD and Bipolar Disorder in Clinical Practice
05/14/2024

With Rakesh Jain, MD, and Craig Chepke, MD

With Rakesh Jain, MD, and Craig Chepk...
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig...
05/14/2024
Psych Congress Network
Pencils spell out quiz on their erasers
Quiz
Which tech challenges can telehealth providers expect to encounter most often?
05/14/2024
Hone your telepsychiatry skills with this quiz!
Hone your telepsychiatry skills with this quiz!
Hone your telepsychiatry skills...
05/14/2024
Psych Congress Network
Greg Mattingly, MD
Videos
The Future Role of Orexin Agonists for the Treatment of Narcolepsy, EDS, and Beyond
05/13/2024

Featuring Greg Mattingly, MD

Featuring Greg Mattingly, MD
Greg Mattingly, MD, explains how sleep can become disrupted and the novel solutions that the orexin receptor may make possible.
Greg Mattingly, MD, explains how sleep can become disrupted and the novel solutions that the orexin receptor may make possible.
Greg Mattingly, MD, explains how...
05/13/2024
Psych Congress Network
A depressed teen rides the bus and looks at a smartphone in their hand
News
Adolescents May Not Reliably Signal Self-Harm Risk on PHQ in Primary Care Screenings
05/13/2024
Jolynn Tumolo
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were...
05/13/2024
Psych Congress Network

News Articles

Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
News
Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
04/29/2024
Jolynn Tumolo
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease...
04/29/2024
Neurology
Illustration of the brain
News
Antipsychotics for Dementia Associated With More Adverse Outcomes Than Previously Thought
04/22/2024
Jolynn Tumolo
Antipsychotic use in patients with dementia is associated with an increased risk for a handful of serious adverse outcomes, including pneumonia, acute kidney injury, venous thromboembolism, and stroke.
Antipsychotic use in patients with dementia is associated with an increased risk for a handful of serious adverse outcomes, including pneumonia, acute kidney injury, venous thromboembolism, and stroke.
Antipsychotic use in patients...
04/22/2024
Psych Congress Network
Doctors examine brain scans
News
Rate of Frontotemporal Dementia in Patients With ALS Higher Than Previous Estimates
03/04/2024
Jolynn Tumolo
More than a third of patients with amyotrophic lateral sclerosis (ALS) had neuropathological signs of frontotemporal dementia, according to study results published in Brain.
More than a third of patients with amyotrophic lateral sclerosis (ALS) had neuropathological signs of frontotemporal dementia, according to study results published in Brain.
More than a third of patients...
03/04/2024
Neurology
Brain scan
News
Study Reveals Structural Brain Subgroups in Aging, Key for Early Disease Detection
03/01/2024
Meagan Thistle
Recent study reveals significant insights into the structural brain changes associated with aging in individuals without diagnosed cognitive impairment.
Recent study reveals significant insights into the structural brain changes associated with aging in individuals without diagnosed cognitive impairment.
Recent study reveals significant...
03/01/2024
Psych Congress Network
A doctor examines MRI scans of a brain.
News
Low-Dose IL-2 Shows Potential for Alzheimer Disease, Phase 2a Trial Underway
02/07/2024
Jolynn Tumolo
After promising findings in a small, open-label, phase 1 pilot study of low-dose interleukine-2 (IL-2) immunotherapy in patients with Alzheimer disease (AD), researchers are proceeding with a double-blinded, randomized, placebo-controlled,...
After promising findings in a small, open-label, phase 1 pilot study of low-dose interleukine-2 (IL-2) immunotherapy in patients with Alzheimer disease (AD), researchers are proceeding with a double-blinded, randomized, placebo-controlled,...
After promising findings in a...
02/07/2024
Neurology
Hearing Loss Prevention Could Delay, Prevent Dementia Onset
News
Hearing Loss Prevention Could Delay, Prevent Dementia Onset
01/29/2024
Evi Arthur
Hearing aids could delay or prevent dementia onset, according to a population-based cohort study recently published in the journal JAMA Otolaryngology Head & Neck Surgery.
Hearing aids could delay or prevent dementia onset, according to a population-based cohort study recently published in the journal JAMA Otolaryngology Head & Neck Surgery.
Hearing aids could delay or...
01/29/2024
Psych Congress Network
Excessive TV Use Could Raise Risk of Dementia, PD, and Depression
News
Excessive TV Use Could Raise Risk of Dementia, PD, and Depression
01/15/2024
Evi Arthur
Excessive TV watching was associated with an increased risk of dementia, Parkinson disease (PD), and depression, according to recent study results.
Excessive TV watching was associated with an increased risk of dementia, Parkinson disease (PD), and depression, according to recent study results.
Excessive TV watching was...
01/15/2024
Neurology
Multiple Modifiable Risk Factors Connected to Young-Onset Dementia
News
Multiple Modifiable Risk Factors Connected to Young-Onset Dementia
01/10/2024
Evi Arthur
Factors such as social isolation, vitamin D deficiency, and alcohol use disorder, among others, were significantly associated with a higher risk of young-onset dementia (YOD) in a recent prospective cohort study published in JAMA Neurology. 
Factors such as social isolation, vitamin D deficiency, and alcohol use disorder, among others, were significantly associated with a higher risk of young-onset dementia (YOD) in a recent prospective cohort study published in JAMA Neurology. 
Factors such as social...
01/10/2024
Neurology
alzheimer sleep
News
Decline in Slow-Wave Sleep Linked to Increased Dementia Risk
11/30/2023
Meagan Thistle
Researchers have identified a potential link between decreased slow-wave sleep (SWS)—a crucial sleep cycle phase—and Alzheimer risk.
Researchers have identified a potential link between decreased slow-wave sleep (SWS)—a crucial sleep cycle phase—and Alzheimer risk.
Researchers have identified a...
11/30/2023
Psych Congress Network
BIIB080 Reduces Tau Biomarkers in Patients With Mild Alzheimer Disease
News
BIIB080 Reduces Tau Biomarkers in Patients With Mild Alzheimer Disease
11/28/2023
Jolynn Tumolo
BIIB080 reduced biomarkers associated with tau pathophysiology in patients with mild Alzheimer disease, according to results from a phase 1b trial published in JAMA Neurology.
BIIB080 reduced biomarkers associated with tau pathophysiology in patients with mild Alzheimer disease, according to results from a phase 1b trial published in JAMA Neurology.
BIIB080 reduced biomarkers...
11/28/2023
Psych Congress Network
News
One Year After ‘X Waiver’ Axing, Few New Patients Prescribed Meds for OUD
05/15/2024
Brionna Mendoza
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of...
05/15/2024
Psych Congress Network
ketamine brain image
News
Study Findings Support Esketamine and Psilocybin as Effective TRD Treatments
05/14/2024
Meagan Thistle
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and...
05/14/2024
Psych Congress Network
A depressed teen rides the bus and looks at a smartphone in their hand
News
Adolescents May Not Reliably Signal Self-Harm Risk on PHQ in Primary Care Screenings
05/13/2024
Jolynn Tumolo
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were screened in primary care had higher odds of responding “not at all” to a question about thoughts of death or self-harm in the days and weeks before a self-harm event or death by suicide.
Teens with depression who were...
05/13/2024
Psych Congress Network
TD Has ‘Severe Impact’ on Patients and Caregivers
News
TD Has ‘Severe Impact’ on Patients and Caregivers
05/10/2024
Evi Arthur
Tardive dyskinesia (TD) was found to have a “severe impact” on the lives of both patients and their caregivers across physical, psychological, and social domains. Results from the survey-based study were published in the Journal of Patient...
Tardive dyskinesia (TD) was found to have a “severe impact” on the lives of both patients and their caregivers across physical, psychological, and social domains. Results from the survey-based study were published in the Journal of Patient...
Tardive dyskinesia (TD) was...
05/10/2024
Psych Congress Network
Stimulant Use May Increase Heart Damage Risk in Young Adults With ADHD
News
Stimulant Use May Increase Heart Damage Risk in Young Adults With ADHD
05/07/2024
Evi Arthur
Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology. 
Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology. 
Stimulant use for...
05/07/2024
Psych Congress Network
woman looking down on phone
News
MDD Prevalence Tripled in Female Huntington Disease Patients
05/07/2024
Jolynn Tumolo
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major health system was 3 times higher in female patients with Huntington disease (HD) than in male patients, according to a poster presentation APA Annual Meeting.
The prevalence of MDD at a major...
05/07/2024
Psych Congress Network
brain imaging
News
Overlooked Concussion in Children May Cause Mental Health Comorbidities
05/02/2024
Meagan Thistle
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant symptoms after head injury are more likely to experience mental and social disturbances and require mental health services, but 23% aren't being evaluated for concussion or brain trauma.
Children who show significant...
05/02/2024
Psych Congress Network
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
News
ADHD Medication Use, Particularly Stimulants, Tied to Fewer Hospitalizations
05/01/2024
Evi Arthur
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of medication for ADHD, especially lisdexamphetamine and other stimulants, was associated with fewer hospitalizations, and lower suicidal behavior, according to results published in JAMA Network Open. 
In a recent cohort study, use of...
05/01/2024
Psych Congress Network
FDA approval stamp
News
FDA Approves First Prescription Digital Therapeutic for Adjunctive Major Depressive Disorder Treatment
04/30/2024
Meagan Thistle
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as the first prescription digital therapeutic for the treatment of MDD symptoms as an adjunct to clinician-managed outpatient care for adult patients.
Rejoyn has been FDA approved as...
04/30/2024
Psych Congress Network
Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
News
Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
04/29/2024
Jolynn Tumolo
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease...
04/29/2024
Neurology

Posters

Zuranolone Safety and Tolerability in Adults with Postpartum Depression: Analyses from SKYLARK, a 50 mg Placebo-Controlled Study
In the SKYLARK Study, zuranolone 50 mg was generally well tolerated in adults with postpartum depression; treatment-emergent adverse events (TEAEs) led to zuranolone dose reduction and di...
10/26/2023
Utilization of Psychiatric Pharmacogenomic Testing by Primary Care Physicians and Advanced Practice Providers: Confidence and Implementation Barriers
Routine implementation of pharmacogenomic testing for mental health and other conditions treated in primary care may require overcoming barriers such as cost to the patient and knowledge ...
10/26/2023
Valbenazine Improves Tardive Dyskinesia With or Without Concomitant Antipsychotic Therapy: A Meta-Analysis of Three Long-Term Valbenazine Trials
Valbenazine is indicated for once-daily treatment of tardive dyskinesia (TD), a movement disorder associated with prolonged antipsychotic exposure. Data from 3 long-term studies (KINECT™-...
10/26/2023
Veterans’ Intensive​ PCMHI Boot Camp​ (VIP Boot Camp)
Veterans Intensive Primary Care Mental Health Integration Bootcamp (VIP Bootcamp): An upstream solution to Mental Health(MH) access issues within the VA system
10/26/2023
Viloxazine ER (Qelbree®) Administered with Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Topline Results of a Phase IV Safety Trial
Results of a phase IV, open-label safety study evaluating viloxazine ER (Qelbree®) administered with psychostimulants in pediatric (6-17 years) ADHD; morning vs. evening administration of...
10/26/2023
Withdrawal Catatonia: A Rare Case of Treatment-Resistant Catatonia Secondary to Quetiapine Withdrawal
Catatonia is a psychomotor syndrome with well-defined clinical characteristics, although the neurological mechanisms involved remain unknown. In this study, we report a case of a patient ...
10/26/2023
Understanding the Real-World Prescription Patterns and Impact of Atypical Antipsychotic Augmentation Timing on Healthcare Cost in Adult Major Depressive Disorder in the United States: A Systematic Literature Review
This study examined the utilization pattern of augmentation with atypical antipsychotics after partial or no response to antidepressants in patients with MDD. The antidepressant prescript...
10/26/2023
Unique Features of the Rapid Mood Screener Enable Detection of Bipolar I Disorder in a Primary Care Practice
The Rapid Mood Screener (RMS) is a self-administered screening tool to help differentiate bipolar I disorder from major depressive disorder. Cases were identified from a primary care sett...
10/26/2023
Use Of VMAT2 Inhibitors For Tardive Dyskinesia In Geriatric Populations - A Case Study
This case report discusses the safety and efficacy of VMAT2 inhibitors in treating antipsychotic induced tardive dyskinesia in adults >55 years old. It also highlights the increased ri...
10/26/2023
Using Chess as a Novel Means to Cure Treatment Refractory Catatonia
The subject matter of the poster includes a case report of a patient with treatment refractory catatonia whose condition rapidly improved following a game of chess, one of the patient's k...
10/26/2023

Advertisement

Advertisement

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Recent Stories

Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
News
Genetic Variant Appears to Protect Against Alzheimer Disease in At-Risk Individuals
04/29/2024
Jolynn Tumolo
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease the odds of developing Alzheimer disease (AD) by as much as 70% in people who carry the APOE ε4 allele, which is known to significantly increase AD risk. Researchers published the findings online in Acta...
A genetic variant may decrease...
04/29/2024
Neurology
Illustration of the brain
News
Antipsychotics for Dementia Associated With More Adverse Outcomes Than Previously Thought
04/22/2024
Jolynn Tumolo
Antipsychotic use in patients with dementia is associated with an increased risk for a handful of serious adverse outcomes, including pneumonia, acute kidney injury, venous thromboembolism, and stroke.
Antipsychotic use in patients with dementia is associated with an increased risk for a handful of serious adverse outcomes, including pneumonia, acute kidney injury, venous thromboembolism, and stroke.
Antipsychotic use in patients...
04/22/2024
Psych Congress Network
Doctors examine brain scans
News
Rate of Frontotemporal Dementia in Patients With ALS Higher Than Previous Estimates
03/04/2024
Jolynn Tumolo
More than a third of patients with amyotrophic lateral sclerosis (ALS) had neuropathological signs of frontotemporal dementia, according to study results published in Brain.
More than a third of patients with amyotrophic lateral sclerosis (ALS) had neuropathological signs of frontotemporal dementia, according to study results published in Brain.
More than a third of patients...
03/04/2024
Neurology
Brain scan
News
Study Reveals Structural Brain Subgroups in Aging, Key for Early Disease Detection
03/01/2024
Meagan Thistle
Recent study reveals significant insights into the structural brain changes associated with aging in individuals without diagnosed cognitive impairment.
Recent study reveals significant insights into the structural brain changes associated with aging in individuals without diagnosed cognitive impairment.
Recent study reveals significant...
03/01/2024
Psych Congress Network
An elderly patient with Alzheimer disease looks up at their caregiver
AVP-786 Falls Short in Phase 3 Trial for Agitation in Alzheimer Patients
02/16/2024
Meagan Thistle
Otsuka Pharmaceutical Co., Ltd. unveiled the topline results of the phase 3 clinical trial of AVP-786 in treating agitation associated with dementia due to Alzheimer disease.
Otsuka Pharmaceutical Co., Ltd. unveiled the topline results of the phase 3 clinical trial of AVP-786 in treating agitation associated with dementia due to Alzheimer disease.
Otsuka Pharmaceutical Co., Ltd....
02/16/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement